Back to results
US 7,632,862 B2Granted
Pharmaceutical compositions that modulate HPTPbeta activity
AssigneeThe Procter & Gamble Company
InventorsKevin Gene Peters, Michael Glen Davis
Life of this patent
Estimating the term…
Abstract
HPTPbeta is useful as a target in screening agents effective for the treatment of angiogenesis mediated disorders.
Claims4
A pharmaceutical composition, comprising:
- a) an effective amount of (R)-[1-methylcarbamoyl-2-(4-sulfoaminophenyl)ethyl]-carbamic acid tert-butyl ester;
- and
- b) a pharmaceutically-acceptable carrier.
A pharmaceutical composition for modulating an angiogenesis mediated disorder, comprising:
- a) about 500 μM of (R)-[1-methylcarbamoyl-2-(4-sulfoaminophenyl)ethyl]-carbamic acid tert-butyl ester;
- and
- b) a pharmaceutically-acceptable liquid carrier.
Dependencies are inferred from the claim text.